Dr. deGoma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# Ast
Philadelphia, PA 19104Phone+1 215-615-4949Fax+1 215-614-0069
Education & Training
- Hospital of the University of PennsylvaniaPost-Doctoral Fellowship, 2010 - 2011
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2007 - 2010
- Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2006 - 2007
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2004 - 2006
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2003 - 2004
- Harvard Medical SchoolClass of 2003
- Harvard UniversityBA, Biochemical Sciences, Magna Cum Laude, 1972
Certifications & Licensure
- MA State Medical License 2017 - 2025
- PA State Medical License 2010 - 2024
- CA State Medical License 2004 - 2011
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- AHA Population Science Poster Competition Winner 2006
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Assessment Of Vascular Health After Niacin Therapy (AVANT) Start of enrollment: 2012 Mar 01
- Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- Human Genetic Evidence to Inform Clinical Development of IL-6 Signaling Inhibition for Abdominal Aortic Aneurysm.Stephen Burgess, Héléne T Cronjé, Emil deGoma, Yung Chyung, Dipender Gill
Arteriosclerosis, Thrombosis, and Vascular Biology. 2024-12-05 - IL-6 and Cardiovascular Risk: A Narrative Review.Nehal N Mehta, Emil deGoma, Michael D Shapiro
Current Atherosclerosis Reports. 2024-11-26 - 32 citationsVadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese...Masaomi Nangaku, Youssef M.K. Farag, Emil M. deGoma, Wenli Luo, Dennis Vargo
Nephrology, Dialysis, Transplantation. 2021-06-28
Journal Articles
- Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis.deGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ, Atherosclerosis 2012;224:274-9
- Targeting high density lipoproteins in the prevention of cardiovascular disease.Larach D, deGoma EM, Rader DJ, Curr Cardiol Rep
- Approach to the Patient with Extremely Low HDL- Cholesterol.Rader DJ, deGoma EM, J Clin Endocrinol Metab 2012;97:3399-407
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Clinical significance of HDL-C levels among patients with LDL-C < 60 mg/dL.deGoma EM, Leeper NJ, Heidenreich PA, AHA Scientific Sessions
- Statin use in patients with low LDL-C is associated with improved survival.Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA, AHA Scientific Sessions
Lectures
- Subclinical atherosclerosis imaging.Perelman School of Medicine at the University of Pennsylvania. Cardiology Grand Rounds. Philadelphia
- Coronary artery calcium scanning for cardiovascular risk refinement.Perelman School of Medicine at the University of Pennsylvania. Medicine Grand Rounds. Philadelphia
Press Mentions
- New Review Finds Statin Use Not Linked to a Decline in Cognitive FunctionFebruary 10th, 2016
Professional Memberships
- Fellow
- Fellow
- Fellow
- Member
- Society for Vascular MedicineMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: